Table 5
Lymphatic and haematopoietic tissue cancers by cell type and period of hire, men only, Richmond and El Segundo refineries, 1950–95
| Richmond | El Segundo | Combined | |||||||
| <1949 | ≥1949 | Total | <1949 | ≥1949 | Total | <1949 | ≥1949 | Total | |
| Acute lymphatic leukaemia (ALL, ICD-8 204.0): | |||||||||
| Observed | 0 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 4 |
| Expected | 1.16 | 0.68 | 1.83 | 0.64 | 0.41 | 1.02 | 1.79 | 1.07 | 2.86 |
| SMR | 0 | 294.9 | 109 | 312.5 | 0 | 195.4 | 111.6 | 187.7 | 140.0 |
| 95% CI | 0 to 316.2 | 33 to 1061.9 | 12.3 to 394.6 | 35 to 1128.3 | 0 to 894.6 | 22.0 to 707.9 | 12.6 to 403.4 | 21.0 to 674.9 | 37.2 to 358.1 |
| Chronic lymphatic leukaemia (CLL, ICD-8 204.1): | |||||||||
| Observed | 6 | 0 | 6 | 3 | 0 | 3 | 9 | 0 | 9 |
| Expected | 4.83 | 1.34 | 6.16 | 2.73 | 0.85 | 3.47 | 7.54 | 2.12 | 9.66 |
| SMR | 124.3 | 0 | 97.3 | 110 | 0 | 86.5 | 119.3 | 0 | 93.1 |
| 95% CI | 45.4 to 270.4 | 0 to 431.5 | 35.6 to 202.0 | 22.1 to 321.1 | 0 to 431.5 | 17.4 to 252.6 | 54.5 to 226.6 | 0 to 173.0 | 42.5 to 176.9 |
| Acute myeloid leukaemia (AML, ICD-8 205.0): | |||||||||
| Observed | 9 | 2 | 11 | 5 | 1 | 6 | 14 | 3 | 17 |
| Expected | 6.27 | 3.31 | 9.57 | 3.43 | 2.04 | 5.37 | 9.68 | 5.24 | 14.92 |
| SMR | 143.6 | 60.5 | 114.9 | 145.7 | 29 | 111.7 | 144.6 | 57.3 | 114.0 |
| 95% CI | 65.5 to 272.5 | 6.8 to 218.2 | 57.3 to 205.7 | 47.0 to 340.2 | 0.6 to 272.7 | 40.8 to 243.2 | 79.0 to 242.7 | 11.5 to 167.3 | 66.3 to 182.4 |
| Chronic myeloid leukaemia (CML, ICD-8 205.1): | |||||||||
| Observed | 2 | 0 | 2 | 1 | 0 | 1 | 3 | 0 | 3 |
| Expected | 2.79 | 1.51 | 4.3 | 1.54 | 0.93 | 2.42 | 4.31 | 2.4 | 6.71 |
| SMR | 71.7 | 0 | 46.5 | 65.1 | 0 | 41.3 | 69.5 | 0 | 44.7 |
| 95% CI | 8.1 to 258.8 | 0 to 242.9 | 5.2 to 167.9 | 0.9 to 361.3 | 0 to 394.4 | 0.5 to 229.9 | 14.0 to 203.4 | 0 to 152.8 | 9.9 to 130.6 |
| Non-Hodgkin's lymphoma (NHL, ICD-8 200, 202): | |||||||||
| Observed | 26 | 4 | 30 | 6 | 5 | 11 | 32 | 9 | 41 |
| Expected | 17.14 | 8.12 | 25.26 | 9.38 | 5.05 | 14.17 | 26.47 | 12.87 | 39.34 |
| SMR | 151.7 | 49.3 | 118.8 | 64 | 99.1 | 77.6 | 120.9 | 69.9 | 104.2 |
| 95% CI | 99.1 to 222.3 | 13.3 to 126.1 | 80.1 to 169.6 | 23.4 to 139.2 | 31.9 to 231.1 | 38.8 to 139.4 | 82.7 to 170.7 | 31.9 to 132.8 | 74.8 to 141.4 |
| Multiple myeloma (MM, ICD-8 203): | |||||||||
| Observed | 15 | 5 | 20 | 7 | 2 | 9 | 22 | 7 | 29 |
| Expected | 8.67 | 3.02 | 11.68 | 4.79 | 1.91 | 6.55 | 13.43 | 4.79 | 18.22 |
| SMR | 173.1 | 165.6 | 171.2 | 146.1 | 104.9 | 137.4 | 163.8 | 146.1 | 159.2 |
| 95% CI | 96.8 to 285.4 | 53.4 to 386.4 | 104.6 to 264.5 | 58.6 to 301.1 | 11.8 to 378.1 | 62.7 to 260.9 | 102.6 to 248.0 | 58.6 to 301.1 | 106.7 to 228.9 |
